GlassScriptPhysician profile
Tiffany Lai
NPI 1437491776
$3,359.86
in general payments reported to CMS, 2019-2025
12 companies · $529 in 2025
The $529 reported for 2025 was more than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.15 · 2021: $111 · 2022: $225 · 2023: $1,247 · 2024: $1,228 · 2025: $529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,688 · Travel and Lodging: $229 · Education: $64.50 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,687.50 |
| Travel and Lodging | $229.28 |
| Education | $64.50 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $758.75 | 2023 | Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $736.16 | 2021-2024 | Jemperli, Zejula |
| Abbvie INC. | $729.91 | 2024-2025 | |
| Karyopharm Therapeutics INC. | $358.80 | 2024 | Xpovio |
| Immunogen, INC. | $223.04 | 2023-2024 | Elahere, Elahere |
| Seagen INC. | $154.58 | 2023 | |
| Eisai INC. | $125.00 | 2025 | |
| Genmab U.S., INC. | $87.46 | 2024 | Tivdak |
| Caris Mpi, INC. | $79.93 | 2025 | Mi Cancer Seek |
| Astrazeneca Pharmaceuticals LP | $78.47 | 2019-2025 | Lynparza |
| Merck Sharp & Dohme LLC | $14.62 | 2025 | |
| Medical Device Business Services, INC. | $13.14 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Lai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.